Evidence map›Paper›PMID 29208234›Full record

ArticlePlacenta2017

Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration.

Melissa Westwood, Khiria Al-Saghir, Sarah Finn-Sell, Cherlyn Tan, Elizabeth Cowley, Stéphane Berneau, Daman Adlam, Edward D Johnstone

Open access · hybridAbstract read
In one paragraph

Article in Placenta, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Inhibition of LAMP3 mediates the protective effect of vitamin D against hypoxia/reoxygenation in trophoblast cells.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Melissa WestwoodMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Khiria Al-SaghirMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Sarah Finn-SellMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Cherlyn TanMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Elizabeth CowleyMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Stéphane BerneauMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Daman AdlamMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Edward D JohnstoneMaternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK; Maternal and Fetal Health Research Centre, St Mary's Hospital, Central Manchester Universities NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK. Electronic address: edward.johnstone@manchester.ac.uk.
Manchester Academic Health Science Centre · GB

Funding

Medical Research Council MR/M02296X/1
6 · The paper itself

Abstract

introductionFailure of trophoblast invasion and remodelling of maternal blood vessels leads to the pregnancy complication pre-eclampsia (PE). In other systems, the sphingolipid, sphingosine-1-phosphate (S1P), controls cell migration therefore this study determined its effect on extravillous trophoblast (EVT) function.

methodsA transwell migration system was used to assess the behaviour of three trophoblast cell lines, Swan-71, SGHPL-4, and JEG3, and primary human trophoblasts in the presence or absence of S1P, S1P pathway inhibitors and 1,25(OH)

resultsEVTs express S1P receptors 1, 2 and 3. S1P inhibited EVT migration. This effect was abolished in the presence of the specific S1PR2 inhibitor, JTE-013 (p < 0.05 versus S1P alone) whereas treatment with the S1R1/3 inhibitor, FTY720, had no effect. In other cell types S1PR2 is regulated by vitamin D; here we found that treatment with 1,25(OH) DISCUSSION: This study demonstrates that although EVT express three S1P receptor isoforms, S1P predominantly signals through S1PR2/Gα

Indexed as

Cell MovementPlacentationCell LineFemaleHumansLysophospholipidsPregnancyReceptors, LysosphingolipidSphingosineSphingosine-1-Phosphate ReceptorsTrophoblastsVitamin DLysophospholipidsReceptors, LysosphingolipidS1PR2 protein, humanSphingosinesphingosine 1-phosphateSphingosine-1-Phosphate ReceptorsVitamin DGPCRLipid signallingMigrationPlacentaPre-eclampsiaS1PTrophoblastVitamin D

Identifiers

PMID29208234
PMCPMC5754325
OpenAlexW2760320244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.